Generics 32

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Mirabegron manufacturers

32 products found

Filters

32 products found

mirabegron

Tablets, prolonged release (PR) 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #419

The manufacturer based in Europe, has decades of experience in the industry. They focus on a diverse range of products, including prescription drugs, over-the-counter medications, and medical devices. Their portfolio covers a variety of therapeutic areas, with key focuses on cardiovascular health, oncology, and pain management. The manufacturer holds numerous patents for their innovative products and adheres to strict GMP standards for both the European Union and the United States. They distribute their products across key regions in Europe, North America, and other international markets. Their production lines include solid oral dosage forms, injectables, and liquids, offering a wide range of treatment options for patients.

Manufacturer usually replies in 5 days

mirabegron

Tablets, prolonged release (PR) 25 mg, 50 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Uruguay
Available for
Licensing with supply
Comments
Reference product: Betmiga
Manufacturer #19112
A pharmaceutical manufacturer based in the EU that develops and produces generic medicines and sells its products in the EU, North America, LATAM, and Africa. Main therapeutic areas include diabetes, urology, and antidepressant. The company possesses its own R&D and regulatory department.

Manufacturer usually replies in 6 days

mirabegron

Oral suspension 10 mg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Modified release oral suspension.Early stage
Manufacturer #8593
It is a private R&D and business development organization established in the 2000s, specializing in the design and development of new pharmaceutical products worldwide. They have an average of 5-6 new developments per year, an average of 8-10 DCPs per year, more than 60 dossier updates in the last 10 years, they have more than 3 valid and approved patent applications, and approximately 140 MAs worldwide.

Manufacturer usually replies in 2 days

Want to see all 32 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Mirabegron

Mirabegron treats overactive bladder. In this condition, the patient’s bladder muscles contract uncontrollably. This leads to frequent urination, urgent need to urinate, and inability to control urination. It can be used as a standalone therapy or in combination with Solifenacin. It has properties similar to antimuscarinic medication like Solifenacin. Its actions activate β3 adrenergic receptor in the bladder, leading to its relaxation. Mirabegron is sold under the brand name Myrbetriq among others. Astellas Pharma Inc. received the First approval for selling in the USA and EU in 2012. In 2017, with more than three million prescriptions, it was in the top 200 most prescribed drugs in the USA.

Dosage Forms & Strengths

Mirabegron is sold as an extended-release tablet in 25mg and 50mg strengths. In the treatment of overactive Bladder, as a Monotherapy, with symptoms of urge urinary incontinence, urgency, and urinary frequency, the dose is 25 mg, per day and it is typically effective within 2 months from the start of the therapy, the dosage can be increased to 50 mg a day dependent on individual efficacy and tolerance.

The price of Mirabegron

In the USA, the consumer has to pay an average retail price of $497.10 for 30 branded tablets. This medicine is much cheaper in the developing part of the world. In India, a supply of 30 tablets of 50mg of oral, tablets costs USD40.

How does Mirabegron work?

Mirabegron is a selective agonist for beta-3 adrenergic receptors with high potency. Upon activation of the beta-3 receptors, the detrusor smooth muscle relaxes to allow for a larger bladder capacity. At 200 mg doses (high), there is a potential to activate beta-1 and beta-2 adrenergic receptors. Its action results in the relaxation of the muscles around the bladder. This eventually results in increased bladder capacity thus reducing the urge or need to pee as frequently or as urgently.

Finding Mirabegron Manufacturers and Suppliers

The best way to find and gain access to Mirabegron manufacturers and Mirabegron suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Mirabegron can be a the time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Mirabegron to work with. You can fine-tune your search results using various filters too, letting you search for Mirabegron from specific countries.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible